Company: CDLX
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0001666071-25-000069
Chunk: 99

Company: Cardlytics, Inc.
Filing Date: 2025-05-07
Form: 10-Q
Item: Item 1
Chunk 99
---
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

2

Table of Contents

CARDLYTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Amounts in thousands, except par value amounts)

March 31, 2025December 31, 2024AssetsCurrent assets:Cash and cash equivalents$52,046 $65,594 Accounts receivable and contract assets, net96,094 103,252 Other receivables3,358 3,801 Prepaid expenses and other assets5,331 5,336 Total current assets156,829 177,983 Long-term assets:Property and equipment, net2,466 2,596 Right-of-use assets under operating leases, net5,062 6,341 Intangible assets, net9,916 11,371 Goodwill159,429 159,429 Capitalized software development costs, net33,867 33,341 Other long-term assets, net1,504 1,650 Total assets$369,073 $392,711 Liabilities and stockholders' equityCurrent liabilities:Accounts payable$4,445 $3,689 Accrued liabilities:Accrued compensation6,442 5,494 Accrued expenses8,378 7,175 Partner Share liability28,759 32,479 Consumer Incentive liability31,800 45,513 Short-term debt45,936 45,863 Deferred revenue2,608 2,154 Current operating lease liabilities1,658 2,025 Current contingent consideration1,825 4,563 Total current liabilities131,851 148,955 Long-term liabilities:Convertible senior notes, net168,009 167,729 Long-term operating lease liabilities5,123 6,034 Total liabilities$304,983 $322,718 Stockholders’ equity:Common stock, $0.0001 par value—100,000 shares authorized, 52,175 and 51,257 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively$10 $10 Additional paid-in capital1,376,692 1,366,958 Accumulated other comprehensive income1,246 3,601 Accumulated deficit(1,313,858)(